Mechanistically, sclerostin inhibition in exercised Gfra2−/− mice normalized BFR, strength, and trabecular thickness (Figures 6F–6H), highlighting the relevance of sclerostin in the osteopenia of Gfra2−/− mice. Here, GFRA2 is linked to Osteopenia.